The Exchange had sought clarification from Aurobindo Pharma with respect to news appearing on CNBC TV18 on November 22, 2016 titled ‘Vietnam Government blacklists Aurobindo Pharma on quality issues.’ Aurobindo Pharma response is enclosed.
The above information is a part of company’s filings submitted to BSE.